Pulmonx, Inc.’s Zephyr Endobronchial Valve Demonstrates Statistically And Clinically Significant Results In A Prospective, Randomized Controlled Trial

REDWOOD CITY, Calif. & MUNICH--(BUSINESS WIRE)--The results of BeLieVeR-HIFi trial, the first double-blinded, randomized, controlled clinical trial to assess the impact of the Zephyr® Endobronchial Valve (EBV) for the treatment of emphysema, were presented today at the 2014 European Respiratory Society Conference in Munich by Nicholas S. Hopkinson, M.D., of The Royal Brompton & Harefield NHS Foundation Trust in London.

Help employers find you! Check out all the jobs and post your resume.